Immunome, Inc. (IMNM) vs Pharvaris N.V. (PHVS)
- Immunome, Inc. IMNM 16.47 −5.34%
- Pharvaris N.V. PHVS 27.82 −6.14%
Immunome, Inc. and Pharvaris N.V. are both Biotechnology companies. Immunome, Inc. and Pharvaris N.V. are of similar size ($2.1B and $2.1B). Across the 11 metrics below, Immunome, Inc. leads on 7 and Pharvaris N.V. on 4.
Valuation
Profitability
| Metric | IMNM | PHVS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (64.03%) | (71.50%) | (56.36%) |
| Return on assets | (59.03%) | (64.43%) | (48.04%) |
| Return on invested capital | (3,322.99%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack